Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.

The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.

Ticks are active again, as shown by the increase in tick bite reports on Tekenradar.nl. Quick action is important: the faster you remove a tick after it bites you, the lower your risk of contracting Lyme disease.

People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.

This week saw the start of babies being vaccinated against the rotavirus. This vaccination is included in the Dutch National Immunisation Programme as of this year. All parents of babies born on or after 1 January 2024 will receive an invitation for this.

In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.

Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.

Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.

A new RIVM study has shown that the COVID-19 pandemic intensified existing socio-economic differences. People on lower incomes visited test lanes less often during the pandemic, but were admitted to hospital and intensive care with COVID-19 more often.

Each year, approximately 27,000 people are diagnosed with Lyme disease. For most, the symptoms disappear after treatment with antibiotics. Unfortunately, 25% of those treated have chronic symptoms, such as fatigue, concentration disorders or pain.